The chemical and pharmaceutical equivalence of sulphadoxine/pyrimethamine tablets sold on the Tanzanian market

被引:17
作者
Hebron, Y [1 ]
Tettey, JNA [1 ]
Pournamdari, M [1 ]
Watson, DG [1 ]
机构
[1] Univ Strathclyde, Dept Pharmaceut Sci, Glasgow G4 0NR, Lanark, Scotland
关键词
liquid chromatography-mass spectrometry; physical and chemical equivalence; sulphadoxine-pyrimethamine;
D O I
10.1111/j.1365-2710.2005.00687.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study investigated chemical and pharmaceutical equivalence of 11 brands of pyrimethamine-sulphadoxine combination tablets sold on the Tanzanian market. Physical and chemical tests were performed for all the 11 brands. These tests included hardness test, friability, disintegration, dissolution, weight uniformity and assay for the active components. All the brands passed all the quality specifications of the United States Pharmacopoeia (USP) and British Pharmacopoeia (BP) in terms of hardness, friability, disintegration, assay and dissolution test, except for three brands that failed the hardness, disintegration or friability tests. One brand failed both the hardness and disintegration test; one failed the hardness test, whereas another one failed the friability test. The percentage content of pyrimethamine in the brands was in the range of 91.04-100.20% whereas that of sulphadoxine ranged from 91.53% to 99.88%. There were no major differences between the different brands of tablets containing pyrimethamine and sulphadoxine and the innovator product (Fansidar(R)), and all brands were physically and chemically equivalent. The results indicate that the post-market surveillance and registration process in Tanzania is having an impact on product quality as there was no brand which could be considered of very poor quality. Impurity profiling of all the locally produced brands indicated that they all contained the same sulphadoxine impurity, which was absent in the innovator product, suggesting a common source of generic raw material.
引用
收藏
页码:575 / 581
页数:7
相关论文
共 12 条
[1]   The quality of sulphadoxine-pyrimethamine and amodiaquine products in the Kenyan retail sector [J].
Amin, AA ;
Snow, RW ;
Kokwaro, GO .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2005, 30 (06) :559-565
[2]   Stability of essential drugs in the field: Results of a study conducted over a two-year period in Burkina Faso [J].
Ballereau, F ;
Prazuck, T ;
Schrive, I ;
Lafleuriel, MT ;
Rozec, D ;
Fisch, A ;
Lafaix, C .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1997, 57 (01) :31-36
[3]  
GENNARO AR, 1995, REMINGTONS PHARM SCI, P1580
[4]   The quality of essential antimicrobial and antimalarial drugs marketed in Rwanda and Tanzania:: influence of tropical storage conditions on in vitro dissolution [J].
Kayumba, PC ;
Risha, PG ;
Shewiyo, D ;
Msami, A ;
Masuki, G ;
Ameye, D ;
Vergote, G ;
Ntawukuliryayo, JD ;
Remon, JP ;
Vervaet, C .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2004, 29 (04) :331-338
[5]  
LACHMAN L, 1986, THEORY PRACTICE IND, P299
[6]   Evaluation of the quality of amodiaquine and sulphadoxine/pyrimethamine tablets sold by private wholesale pharmacies in Dar Es Salaam Tanzania [J].
Minzi, OMS ;
Moshi, MJ ;
Hipolite, D ;
Massele, AY ;
Tomson, G ;
Ericsson, Ö ;
Gustafsson, LL .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2003, 28 (02) :117-122
[7]  
Odeniyi M. A., 2003, Tropical Journal of Pharmaceutical Research, V2, P161
[8]   In vitro evaluation of the quality of essential drugs on the Tanzanian market [J].
Risha, PG ;
Shewiyo, D ;
Msami, A ;
Masuki, G ;
Vergote, G ;
Vervaet, C ;
Remon, JP .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2002, 7 (08) :701-707
[9]   Assessment of the incidence of substandard drugs in developing countries [J].
Shakoor, O ;
Taylor, RB ;
Behrens, RH .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 1997, 2 (09) :839-845
[10]   Pharmacopoeial quality of drugs supplied by Nigerian pharmacies [J].
Taylor, RB ;
Shakoor, O ;
Behrens, RH ;
Everard, M ;
Low, AS ;
Wangboonskul, J ;
Raid, RG ;
Kolawole, JA .
LANCET, 2001, 357 (9272) :1933-1936